Literature DB >> 19826783

Botulinum toxin improves reduced dorsiflexion after Achilles tendon surgery.

Iris Reuter1, Olaf Lorbach, Sabine Mehnert, Manfred Kaps, Martin Engelhardt.   

Abstract

Generally, outcome after surgical repair of complete Achilles tendon rupture is good. However, some patients have ongoing problems with dorsiflexion of the ankle joint. We report on eight patients, who did not achieve heel contact because of reduced ankle dorsiflexion 5 months after surgical repair of complete Achilles tendon rupture. All patients received at least three cycles of injections with 200-300 units of Botulinum toxin A (BOTOX) into the gastrocnemius and soleus muscle. Weakening of the triceps surae by Botulinum toxin allowed patients to perform the required exercises and to tolerate casting at night. Thus, all patients were able to tolerate plantigrade foot position 9 months after beginning of Botulinum toxin treatment. At final follow-up after 2 years, pain had significantly improved, and a mean dorsiflexion of 21 degrees was reached. In conclusion, treatment of the calf muscles with BOTOX is a safe and effective method to improve restricted dorsiflexion in patients after Achilles tendon repair.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19826783     DOI: 10.1007/s00167-009-0948-0

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  13 in total

Review 1.  Expanding use of botulinum toxin.

Authors:  Roongroj Bhidayasiri; Daniel D Truong
Journal:  J Neurol Sci       Date:  2005-08-15       Impact factor: 3.181

2.  Force in the achilles tendon during walking with ankle foot orthosis.

Authors:  Asa Fröberg; Paavo Komi; Masaki Ishikawa; Tomas Movin; Anton Arndt
Journal:  Am J Sports Med       Date:  2009-02-19       Impact factor: 6.202

3.  Evaluating the role of botulinum toxin in the management of focal hypertonia in adults.

Authors:  D Richardson; G Sheean; D Werring; M Desai; S Edwards; R Greenwood; A Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-10       Impact factor: 10.154

4.  Low-dose botulinum toxin with ankle taping for the treatment of spastic equinovarus foot after stroke.

Authors:  F Reiter; M Danni; G Lagalla; G Ceravolo; L Provinciali
Journal:  Arch Phys Med Rehabil       Date:  1998-05       Impact factor: 3.966

5.  Ruptures of the achilles tendon.

Authors:  V J DiStefano; J E Nixon
Journal:  J Sports Med       Date:  1973 Jan-Feb

Review 6.  Achilles tendinopathy.

Authors:  J L Cook; K M Khan; C Purdam
Journal:  Man Ther       Date:  2002-08

Review 7.  [Botulinum toxin A in orthopedic pain therapy].

Authors:  R Placzek; M Söhling; M Gessler; J Jerosch
Journal:  Schmerz       Date:  2004-12       Impact factor: 1.107

8.  A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot.

Authors:  F Mancini; G Sandrini; A Moglia; G Nappi; C Pacchetti
Journal:  Neurol Sci       Date:  2005-04       Impact factor: 3.307

9.  Botulinum toxin use as an adjunctive modality in a patient with multiple flexor tendon ruptures.

Authors:  Wade D Kubat; Mark Rekant
Journal:  Hand (N Y)       Date:  2008-03-14

10.  European consensus table on the use of botulinum toxin type A in adult spasticity.

Authors:  Jörg Wissel; Anthony B Ward; Per Erztgaard; Djamel Bensmail; Martin J Hecht; Thierry M Lejeune; Peter Schnider; Maria C Altavista; Stefano Cavazza; Thierry Deltombe; Esther Duarte; Alexander C H Geurts; Jean-Michel Gracies; Naseer H J Haboubi; Francisco J Juan; Helge Kasch; Christian Kätterer; Yeşim Kirazli; Paolo Manganotti; Yeşim Parman; Tatjana Paternostro-Sluga; Konstantina Petropoulou; Robert Prempeh; Marc Rousseaux; Jaroslaw Slawek; Niko Tieranta
Journal:  J Rehabil Med       Date:  2009-01       Impact factor: 2.912

View more
  1 in total

1.  Botulinum toxin effects on gasatrocnemius strength and plantar pressure in diabetics with peripheral neuropathy and forefoot ulceration.

Authors:  Mary K Hastings; Michael J Mueller; David R Sinacore; Michael J Strube; Beth E Crowner; Jeffrey E Johnson; Brad R Racette
Journal:  Foot Ankle Int       Date:  2012-05       Impact factor: 2.827

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.